4-{2-[6-(bromomethyl)-3,5-dichloro-2-oxopyridin-1(2H)-yl]ethyl}benzonitrile | 1091600-53-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-{2-[6-(bromomethyl)-3,5-dichloro-2-oxopyridin-1(2H)-yl]ethyl}benzonitrile
• 英文别名: 4-[2-[2-(Bromomethyl)-3,5-dichloro-6-oxopyridin-1-yl]ethyl]benzonitrile
• CAS: 1091600-53-1
• 化学式: C₁₅H₁₁BrCl₂N₂O
• 分子量: 386.075
• InChiKey: IFQXIPQXQAHNCK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  44.1
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-{2-[6-(bromomethyl)-3,5-dichloro-2-oxopyridin-1(2H)-yl]ethyl}benzonitrile 、 (2R)-2-isobutylpyrrolidine monohydrochloride 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 4-{2-[3,5-dichloro-2-oxo-6-{[(2R)-2-isobutylpyrrolidin-1-yl]methyl}pyridin-1(2H)-yl]ethyl}benzonitrile
  参考文献：
  名称：

  EP2301922

  摘要：

  公开号：

文献信息

• PYRIDONE COMPOUNDS
  申请人：Kamikubo Takashi

  公开号：US20110082133A1

  公开（公告）日：2011-04-07

  [Problems] A useful compound which can be used as a pharmaceutical, in particular, an agent for treating peripheral arterial occlusive disease is provided. [Means for Solution] The present inventors have conducted extensive studies on EP4 receptor agonists, and as a result, have found that a novel pyridone compound, in which a group having an acidic group is substituted at the 1-position of the pyridone ring, the 6-position is bonded with an aromatic ring group via a linking part, and the linking part contains a nitrogen atom, has an excellent EP4 receptor agonistic action, thereby completing the present invention. Since the compound of the present invention has an excellent EP4 receptor agonistic action, it is useful as a pharmaceutical, in particular, as an agent for treating peripheral arterial occlusive disease.

  [问题] 提供了一种有用的化合物，可以用作药物，特别是用于治疗外周动脉闭塞病的药物。 [解决方法] 现有发明人对EP4受体激动剂进行了广泛的研究，结果发现，一种新的吡啶酮化合物，在其1位取代了一个含有酸性基团的基团，在6位通过连接部分与芳香环基团结合，连接部分含有一个氮原子，具有出色的EP4受体激动作用，从而完成了本发明。由于本发明的化合物具有出色的EP4受体激动作用，因此它可用作药物，特别是作为治疗外周动脉闭塞病的药物。
• PYRIDONE COMPOUND
  申请人：Kamikubo Takashi

  公开号：US20100179137A1

  公开（公告）日：2010-07-15

  [Solving Means] The present inventors have conducted extensive studies on an EP4 receptor agonist, and as a result, found that a novel pyridone compound characterized in that the 1-position in the pyridone ring is substituted with a group having an acidic group such as a carboxyl group and the 6-position is bonded with an aromatic ring group via lower alkyl, lower alkylene, ether, or thioether, has an excellent EP4 receptor agonistic action, thereby completing the present invention. Since the compound of the present invention has an excellent EP4 receptor agonistic action and a blood flow increasing action in the hindlimb of a rat, it is useful as a pharmaceutical, in particular, an agent for treating peripheral arterial occlusive disease.

  【解决方法】本发明者对EP4受体激动剂进行了广泛的研究，并发现一种新型吡啶酮化合物，其特征在于吡啶酮环中的1位被取代为具有酸性基团（如羧基）的基团，而6位则通过较低的烷基、烷基烷基、醚或硫醚与芳香环基团结合，具有极好的EP4受体激动作用，从而完成了本发明。由于本发明的化合物在大鼠后肢具有出色的EP4受体激动作用和增加血流的作用，因此可用作制药用途，特别是治疗周围动脉闭塞性疾病的药物。
• EP2301922
  申请人：——

  公开号：——

  公开（公告）日：——